All treatments
Treatment
Afinitor 5 mg tablets clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic confirmatory (Phase III)
C4391022 - AN INTERVENTIONAL, OPEN-LABEL, RANDOMIZED, MULTICENTER PHASE 3 STUDY OF PF-07220060 PLUS FULVESTRANT COMPARED TO INVESTIGATOR’S CHOICE OF THERAPY IN PARTICIPANTS OVER 18 YEARS OF AGE WITH HORMONE RECEPTOR-POSITIVE, HER2-NEGATIVE ADVANCED/METASTATIC BREAST CANCER WHOSE DISEASE PROGRESSED AFTER PRIOR CDK 4/6 INHIBITOR-BASED THERAPY
This study looks at a new drug (PF-07220060) combined with a standard breast cancer treatment (Fulvestrant). It's for advanced hormone receptor-positive, HER2-negative breast cancer that has grown after previous CDK 4/6 inhibitor treatment. Researchers want to see if the new combination works better.
For: Hormone receptor-positive · her2-negative advanced/metastatic breast cancerSweden · Czechia · Bulgaria - AuthorisedTherapeutic exploratory (Phase II)
Repurposing Everolimus to enhance musculoskeletal Vitality and Ageing in The Elderly (RENOVATE)
This study, called RENOVATE, is looking at whether a drug called Everolimus, usually used for other conditions, can improve bone and muscle health in healthy older adults. It involves comparing Everolimus with a dummy pill and another medicine called Tetracycline.
For: General healthy elderly with stable medical conditionsDenmark